COVID-19 case definitions, diagnostic testing criteria, and surveillance across the pandemic’s 25 highest burden countries
Preprint
Abstract
Objective We compared suspect, probable, and confirmed case definitions, as well as diagnostic testing criteria, used in the COVID-19 pandemic’s 25 highest burden countries to aid interpretation of global and national surveillance data. Methods We identified the COVID-19 pandemic’s 25 countries with the highest disease burden based on the number of cumulative reported cases to the World Health Organization (WHO) as of 1 October 2020. We searched official websites of these countries for suspect, probable, and confirmed case definitions. Given that confirmation of COVID-19 usually requires diagnostic testing, we also searched for diagnostic testing eligibility criteria in these countries. Extracted case definitions and testing criteria were managed in a database and analyzed in Microsoft Excel. Findings We identified suspect, probable, and confirmed case definitions in 96%, 64%, and 100% of countries, respectively. Testing criteria were identified in 100% of countries. 56% of identified countries followed WHO recommendations for using a combination of clinical and epidemiological criteria as part of the suspect case definition. 75% of identified countries followed WHO recommendations on using clinical, epidemiological, and diagnostic criteria for probable cases. 72% of countries followed WHO recommendations on using PCR testing for confirming a case of COVID-19. Finally, 64% of countries used testing eligibility criteria at least as permissive as WHO. Conclusion There is marked heterogeneity in who is eligible for testing in countries and how countries define a case of COVID-19. This affects the ability to compare burden, transmission, and response impact estimates derived from case surveillance data across countries.Keywords
All Related Versions
- Published version: Emerging Infectious Diseases, 28 (1), 148.
This publication has 12 references indexed in Scilit:
- Rethinking Covid-19 Test Sensitivity — A Strategy for ContainmentNew England Journal of Medicine, 2020
- Update on serologic testing in COVID–19Clinica Chimica Acta, 2020
- Effectiveness of COVID-19 case definition in identifying SARS-CoV-2 infection in northern MexicoPopulation Medicine, 2020
- Loss of Taste and Smell as Distinguishing Symptoms of Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Predictive Value of Sudden Olfactory Loss in the Diagnosis of COVID-19ORL, 2020
- Smell and taste symptom‐based predictive model for COVID‐19 diagnosisInternational Forum of Allergy & Rhinology, 2020
- Effect of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China: a modelling studyThe Lancet Public Health, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020Eurosurveillance, 2020
- Considerations in Planning a Surveillance System2010